(Q50747047)

18 March 2018

title

Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? (English)

1 reference

18 March 2018

main subject

psychiatry

0 references

biological psychiatry

1 reference

1

1 reference

18 March 2018

author name string

A G Phillips

series ordinal

2

1 reference

18 March 2018

T R Insel

series ordinal

3

1 reference

18 March 2018

language of work or name

English

0 references

publication date

7 August 2012

1 reference

18 March 2018

published in

Molecular Psychiatry

1 reference

18 March 2018

volume

17

1 reference

18 March 2018

issue

12

1 reference

18 March 2018

page(s)

1174-1179

1 reference

18 March 2018

https://scigraph.springernature.com/pub.10.1038/mp.2012.105

exact match

0 references

cites work

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Evaluation of the diagnostic utility of the TRH-induced TSH response in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

On the controversies about clinical use of EEG brain mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Establishment of Diagnostic Validity in Psychiatric Illness: Its Application to Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

The validation of psychiatric diagnosis: new models and approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Full spectrum of psychiatric outcomes among offspring with parental history of mental disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Dimensions and the psychosis phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Dimensionality and the category of major depressive episode.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Explanatory models for psychiatric illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Why most published research findings are false

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Why Most Discovered True Associations Are Inflated

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Replication and p Intervals: p Values Predict the Future Only Vaguely, but Confidence Intervals Do Much Better

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Statistical power in biological psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Endophenotypes in schizophrenia: a selective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Meta-analysis and the science of schizophrenia: variant evidence or evidence of variants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Functional neuroimaging of working memory in schizophrenia: task performance as a moderating variable.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Problems of spectrum and bias in evaluating the efficacy of diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Translating biomarkers to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Uses and abuses of screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Population screening for genetic disorders in the 21st century: evidence, economics, and ethics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

21 January 2018

Asthma in older adults

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Personalized psychiatry: a realistic goal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

The future (or lack of future) of personalized prescription in psychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Pharmacogenetics and pharmacogenomics: a clinical reality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Can neuroscience be integrated into the DSM-V?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Research domain criteria (RDoC): toward a new classification framework for research on mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

The psychiatric GWAS consortium: big science comes to psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Toward discovery science of human brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

DSM categories and dimensions in clinical and research contexts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Effect size, confidence interval and statistical significance: a practical guide for biologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Gene expression profiling in breast cancer: classification, prognostication, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

Dexamethasone suppression tests in depression and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

7 January 2021

The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

7 January 2021

What is the probability of replicating a statistically significant effect?

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

7 January 2021

The persistence of underpowered studies in psychological research: causes, consequences, and remedies

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

7 January 2021

Adenoviral-mediated gene transfer of Gadd45a results in suppression by inducing apoptosis and cell cycle arrest in pancreatic cancer cell

1 reference

https://api.crossref.org/works/10.1038%2FMP.2012.105

7 January 2021

Identifiers

DOI

10.1038/MP.2012.105

1 reference

18 March 2018

1 reference

18 March 2018